Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis--Report of Two Cases.
about
Alemtuzumab for Multiple Sclerosis.Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications.Safety of monoclonal antibodies for the treatment of multiple sclerosis.Listeria monocytogenes infection associated with alemtuzumab - - a case for better preventive strategies.Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple SclerosisInterdisciplinary Risk Management in the Treatment of Multiple Sclerosis.Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis.Monoclonal Antibodies for Relapsing Multiple Sclerosis: A Review of Recently Marketed and Late-Stage Agents.Infectious Complications of Novel Multiple Sclerosis Therapies.Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS.Listeria rhombencephalitis mimicking a demyelinating event in an immunocompetent young patient.Pulmonary Nocardia beijingensis infection associated with the use of alemtuzumab in a patient with multiple sclerosis.Opportunistic infections after alemtuzumab: New cases of norcardial infection and cytomegalovirus syndrome.Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world.Infections in patients with multiple sclerosis: Implications for disease-modifying therapy.[Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action].
P2860
Q28069730-DC15415C-A79F-4EC6-B68E-A4FBB4762972Q30699740-83403792-AC6F-4253-A525-1C9D9672BA6CQ34542922-9785FAB1-56BC-4614-A5B6-06090CF9871BQ36334825-B4A6D6FC-42EB-49AF-9531-F1963640C5F9Q36484448-0B26E0E8-70DB-427C-96AC-C5CAAFDE398DQ37615119-1C856F82-B863-405C-932E-E9BC2D8A8E62Q38650602-E96906A2-FABE-4E3E-BAF0-A580481EB9FBQ38747100-B73EC306-586C-4D32-B2F7-6D6A332C7371Q38944786-096B22E4-4E41-412F-9BA1-7A8B34251336Q39744600-8A2F95AA-1DB5-414D-800E-D133D0A9A899Q40096309-E984037B-C787-4686-BB32-3C13C5E931ADQ40295328-9573D571-76B2-44B2-98B6-712B6D63C719Q40295332-4D0254CC-F35C-4C6C-91E7-358B02579247Q42361890-2DD6DBAA-32EC-481A-A1AB-C92D128E26E1Q47600984-4D1EFC77-C86A-4F97-9F8A-5286F32DEC5DQ52855510-D833D08D-13DC-4B7C-88BC-CC3E6D86F3C0
P2860
Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis--Report of Two Cases.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Listeria Meningitis Complicati ...... clerosis--Report of Two Cases.
@ast
Listeria Meningitis Complicati ...... clerosis--Report of Two Cases.
@en
type
label
Listeria Meningitis Complicati ...... clerosis--Report of Two Cases.
@ast
Listeria Meningitis Complicati ...... clerosis--Report of Two Cases.
@en
prefLabel
Listeria Meningitis Complicati ...... clerosis--Report of Two Cases.
@ast
Listeria Meningitis Complicati ...... clerosis--Report of Two Cases.
@en
P2093
P2860
P356
P1476
Listeria Meningitis Complicati ...... clerosis--Report of Two Cases.
@en
P2093
Andreas Harth
Antonios Bayas
Daniela Rau
Hayrettin Tumani
Markus Naumann
Michael Lang
P2860
P304
14669-14676
P356
10.3390/IJMS160714669
P407
P50
P577
2015-06-29T00:00:00Z